| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Counted by filing, the last 12 months brought no open-market purchases and 3 sales by 3 insiders worth about $561K. The 12 months before that brought 1 open-market purchase by 1 insider worth about $18K and 14 sales by 4 insiders worth about $1.2M.
All 3 sales in the last 12 months were made under a Rule 10b5-1 trading plan set up in advance.
The largest open-market purchase in the last two years was 2,500 shares by David W Gryska (Director) at an average $7.17 on December 5, 2024, about $18K.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 778.5K | - | - | |
| Other | 425.0K | - | - | |
| Other | 282.6K | - | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Dec 26, 2025 | Daniel Karlin | Chief Medical Officer | Sell10b5-1 | 5,600 | $13.15 | $73,622.64 | -1.3% | |
| Dec 26, 2025 | Robert Barrow | Chief Executive Officer | Sell10b5-1 | 25,791 | $13.15 | $339,071.70 | -3.2% | |
| Dec 26, 2025 | Mark Sullivan | Chief Legal Officer | Sell10b5-1 | 11,276 | $13.15 | $148,244.44 | -3.8% | |
| Sep 25, 2025 | Mark Sullivan | Chief Legal Officer | Sell10b5-1 | 11,278 | $9.77 | $110,186.06 | -3.7% | |
| Sep 25, 2025 | Robert Barrow | Chief Executive Officer | Sell10b5-1 | 25,797 | $9.77 | $252,036.69 | -3.1% | |
| Sep 25, 2025 | Daniel Karlin | Chief Medical Officer | Sell10b5-1 | 7,704 | $9.77 | $75,268.08 | -1.8% | |
| Jun 25, 2025 | Mark Sullivan | Chief Legal Officer | Sell10b5-1 | 11,491 | $6.80 | $78,138.80 | -3.6% | |
| Jun 25, 2025 | Robert Barrow | Chief Executive Officer | Sell10b5-1 | 26,491 | $6.80 | $180,138.80 | -3.1% | |
| Jun 25, 2025 | Daniel Karlin | Chief Medical Officer | Sell10b5-1 | 7,848 | $6.80 | $53,366.40 | -1.8% | |
| Mar 25, 2025 | Daniel Karlin | Chief Medical Officer | Sell10b5-1 | 6,836 | $6.74 | $46,074.64 | -1.5% |